Lantheus

Following the #HAI2025 Day 2 morning sessions, we connected with Luca Passamonti, MD, PhD, Sr. Medical Director, Clinical Research, who spoke about what inspires him, his hope for the future for #AlzheimersDisease patients and the potential role #radiodiagnostic tools may play in support of better patient outcomes.   #FindFightFollow

#TeamLantheus had a great first day at the 17th Annual Human Amyloid Imaging Conference! Inspiring to hear about all the great work being conducted in the field of biomarkers and imaging. We are proud to not only be a supporter of the conference, but also a contributor in the fight against #Alzheimers. Looking forward to the remaining sessions and hearing more from groundbreaking researchers.  #FindFightFollow #HAI2025

We caught up with Aseem Undvall Anand to hear his insights on the kickoff of the 17th Annual Human Amyloid Imaging Conference. Early discussions, including from keynote speaker Keith Johnson, have highlighted the critical role of biomarkers on informing treatment decisions for patients living with #AlzheimersDisease, showcasing their potential to revolutionize patient care. #HAI25 #FindFightFollow

#NEWS: #Lantheus today announced a definitive agreement to acquire Life Molecular Imaging – a subsidiary of Life Healthcare Group dedicated to advancing novel Positron Emission Tomography (PET) #radiopharmaceutical diagnostics.      This all-cash transaction advances Lantheus' leadership in radiopharmaceuticals and enhances the company’s growth profile with the addition of a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients being evaluated for #AlzheimersDisease.    Read the full release: https://bit.ly/40kkfNg   #LeadingRadiopharma #FindFightFollow #LNTH

#TeamLantheus is off to Puerto Rico for the Human Amyloid Imaging Conference, starting January 15th! We’re proud to be sponsoring this meeting focused on PET imaging of amyloid, Tau radiotracers, #AlzheimersDisease and more!     See the program to learn more: https://bit.ly/4fRx8nI      #FindFightFollow #LeadingRadiopharma 

January is National Mentoring Month, a time to recognize the incredible impact mentors have on personal and professional growth. At #Lantheus, we are proud to foster a culture that values mentorship and empowers employees to #BeTheirBest. We are thrilled to welcome our new Co-Op cohort for Spring 2025! Each new member of #TeamLantheus is sure to bring fresh perspectives and innovative ideas that will help us #GoFurther for patients. We look forward to supporting their journey and watching them thrive. Join us in celebrating the power of mentorship and the bright future of our new co-op members! 🎉 #NationalMentoringMonth #FindFightFollow #CoOpCorner 

Is joining a team of innovative professionals and making a difference for patients on your list of 2025 resolutions? Start the year off right and join #TeamLantheus!     We’re looking for talented individuals to join us as we #FindFightFollow disease to deliver better patient outcomes. Browse our #openpositions and find a role that’s right for you.     Cheers to making 2025 a year of growth & opportunities!     https://bit.ly/LNTHCareers     #LantheusIsHiring #LeadingRadiopharma

Happy New Year! 2024 was a year of growth, innovation and collaboration at #Lantheus as we worked to #FindFightFollow disease to deliver better patient outcomes. As we head into 2025, we’re excited to #GoFurther for patients.      Cheers and #HappyNewYear!

Happy #NationalGivingMonth! At Lantheus, giving back goes beyond our innovative science and includes giving back to our local community. To celebrate, our team contributed to the Bedford Fire Department’s Toy Drive and the Middlesex Community College (MCC) Food Pantry. #GoFurther

With 2024 coming to a close, our Chief Executive Officer Brian Markison reflects on all that #TeamLantheus has accomplished on behalf of millions of patients, from delivering innovative diagnostic agents to growing our pipeline and expanding our capabilities to #FindFightFollow disease in new ways. Thank you to our team for allowing us to #GoFurther for patients, partners and providers in 2024. Hear more from Brian. ⬇️